Development and validation of a human brown adipocyte system
Award amount
$224,320Program and phase
SBIR · Phase IAward year
2015Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Zen-Bio, Inc.
- Proposal award date
- 2015-03-01
- Contract end date
- 2016-02-29
- UEI
- LQS2WJFBBUQ3
- Solicitation number
- PA14-071
- Topic code
- 200
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Tuned stem cell extracellular vesicles are a novel chronic wound therapeutic
- A Novel Human Primary Meibomian Gland Cell Platform for Dry Eye Therapeutics
- Selective Tuning of Stem Cell Extracellular Vesicles as a Novel Therapy for Age-related Tendinopathy
- Tuned stem cell extracellular vesicles as a novel chronic wound therapeutic
- A novel class of anti-acne therapeutics
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Electromagnetic reprogramming of systemic metabolism for the treatment of type 2 diabetes
- Next-Gen Oral Therapeutics for Type 2 Diabetes
- Oral Therapeutics Platform for Treating Inborn Errors of Amino Acid Metabolism
- Development of novel therapeutics for obesity and type 2 diabetes
- Metrifonate local application for DFU treatment
Research funding history
25 SBIR/STTR records share this UEI (2003–2019). Reported award amounts total $16,356,237. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services